GTF2A1
Basic information
Region (hg38): 14:81175452-81221377
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GTF2A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 7 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 7 | 0 | 0 |
Variants in GTF2A1
This is a list of pathogenic ClinVar variants found in the GTF2A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-81180262-A-C | not specified | Uncertain significance (Jun 10, 2024) | ||
14-81192559-T-A | not specified | Uncertain significance (Dec 09, 2023) | ||
14-81192567-C-A | not specified | Uncertain significance (Jun 17, 2024) | ||
14-81192585-T-G | not specified | Uncertain significance (Dec 19, 2022) | ||
14-81192705-C-G | not specified | Uncertain significance (Oct 03, 2022) | ||
14-81192745-A-G | not specified | Uncertain significance (Dec 27, 2023) | ||
14-81192830-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
14-81196211-T-C | not specified | Uncertain significance (Mar 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GTF2A1 | protein_coding | protein_coding | ENST00000553612 | 9 | 45926 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.990 | 0.00962 | 125740 | 0 | 5 | 125745 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.13 | 106 | 188 | 0.563 | 0.00000827 | 2474 |
Missense in Polyphen | 45 | 90.325 | 0.4982 | 1202 | ||
Synonymous | 0.933 | 57 | 66.7 | 0.855 | 0.00000312 | 691 |
Loss of Function | 4.03 | 2 | 22.8 | 0.0879 | 9.75e-7 | 249 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000355 | 0.0000352 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: TFIIA is a component of the transcription machinery of RNA polymerase II and plays an important role in transcriptional activation. TFIIA in a complex with TBP mediates transcriptional activity. {ECO:0000269|PubMed:11030333, ECO:0000269|PubMed:16537915}.;
- Pathway
- Basal transcription factors - Homo sapiens (human);Viral carcinogenesis - Homo sapiens (human);Disease;Signal Transduction;Gene expression (Transcription);the information processing pathway at the ifn beta enhancer;carm1 and regulation of the estrogen receptor;Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;HIV Transcription Initiation;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Infectious disease;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;Signaling by Nuclear Receptors;chromatin remodeling by hswi/snf atp-dependent complexes;Estrogen-dependent gene expression;ESR-mediated signaling
(Consensus)
Recessive Scores
- pRec
- 0.178
Intolerance Scores
- loftool
- 0.147
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.68
Haploinsufficiency Scores
- pHI
- 0.816
- hipred
- Y
- hipred_score
- 0.682
- ghis
- 0.697
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.986
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gtf2a1
- Phenotype
- cellular phenotype; endocrine/exocrine gland phenotype; skeleton phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;snRNA transcription by RNA polymerase II;positive regulation of nucleic acid-templated transcription
- Cellular component
- nucleoplasm;transcription factor TFIID complex;transcription factor TFIIA complex;cytosol
- Molecular function
- RNA polymerase II repressing transcription factor binding;DNA binding;transcription coactivator activity;protein binding;transcription factor binding;TBP-class protein binding;protein heterodimerization activity